Skip to main content

Table 2 Use of antidepressants, anxiolytics and sleeping medications among those with PHQ-9 ≥ 10 and GAD-7 ≥ 10

From: Prevalence of symptoms, ever having received a diagnosis and treatment of depression and anxiety, and associations with health service use amongst the general population in two Russian cities

 

N with medication data

Use of anti-depressants (N06A)

Use of anxiolytics (N05B)

Use of sleeping medication (N05C)

Moderate depression (PHQ-9 ≥ 10)

 Total

334

1.5%

0.6%

1.5%

 Men

86

0.0%

0.0%

0.0%

 Women

248

2.0%

0.8%

2.0%

Moderate anxiety (GAD-7 ≥ 10)

 Total

181

2.2%

0.6%

2.8%

 Men

46

0.0%

0.0%

0.0%

 Women

138

2.9%

0.7%

3.7%

Co-morbid moderate depression and anxiety (PHQ-9 & GAD-7 ≥ 10)

 Total

121

3.3%

0.8%

3.3%

 Men

26

0.0%

0.0%

0.0%

 Women

95

4.2%

1.1%

4.2%